Current guidelines used to plan salvage radiation treatments in patients with local recurrence of prostate cancer should be updated to take into consideration information derived from novel imaging modalities, such as PSMA PET, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2022 Annual Meeting. The study showed that PSMA PET […]
A targeted radionuclide alpha therapy, 225Ac-DOTATATE, has been shown to have long-term anti-tumour effects in patients with advanced-stage gastroenteropancreatic neuroendocrine tumours (GEP-NETs). Results from the Phase II study showed promising survival rates, high response rates and an acceptable toxicity profile, making 225Ac-DOTATATE a potential treatment option for patients who have exhausted other forms of therapy. […]
Novel radiopharmaceutical pair detects and treats melanoma; Study shows potential for broad application in solid tumours
A novel artificial intelligence method can be used to generate high-quality “PET/CT” images and subsequently decrease radiation exposure to the patient. Developed by the U.S. National Cancer Institute, the method bypasses the need for CT-based attenuation correction, potentially allowing for more frequent PET imaging to monitor disease and treatment progression without radiation exposure from CT […]
A new PET imaging technique can greatly reduce the amount of patient radiation exposure by eliminating the need for an accompanying CT scan. Without the CT scan, the amount of radiation delivered to the patient is cut dramatically, which benefits all patients, but in particular the paediatric population and those in need of multiple scans. […]
A new PET imaging agent, 18F-AlF-FAPI-74, has been found to effectively monitor and predict treatment response of an up-and-coming cancer therapy. This non-invasive imaging approach has the potential to help inform important clinical decision-making early in the course of treatment – including re-dosing of therapy, dose optimization, change of therapeutic course, and many more – […]
A cardiac SPECT imaging system using self-collimation performs scans 10 to 100 times faster than current SPECT systems, according to new research presented at the Society of Nuclear Medicine and Molecular Imaging 2022 Annual Meeting. The advantages of selfcollimation SPECT include dramatically shortened scan time, better image quality, increased patient throughput, and reduced radiation exposure […]
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced the creation of the Mars Shot Fund, an initiative to raise $100 million to help pay for research into nuclear medicine, molecular imaging, and therapy. To date the fund has received $600,000 in grants and pledges, and work is underway to increase US federal spending […]
The Society of Nuclear Medicine and Molecular Imaging held this year’s Annual Meeting in Vancouver, Canada from June 11-14. International Hospital looks at some of the research presented at the event.
Sophos, a global leader in cybersecurity, has published a new sectoral survey report, “The State of Ransomware in Healthcare 2022.” The findings reveal that ransomware attacks on health organizations almost doubled from 34% in 2020 to 66% in 2021.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
